Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease Among Hospital Staff

被引:2
|
作者
Zhang, Daya [1 ]
Zhang, Lijun [2 ]
Chen, Shiju [1 ]
Chen, Runxiang [1 ]
Zhang, Xiaodong [1 ]
Bai, Feihu [3 ,4 ,5 ]
机构
[1] Hainan Med Univ, Grad Sch, Haikou, Peoples R China
[2] Hainan Med Univ, Affiliated Hosp 2, Med Examinat Ctr, Haikou, Peoples R China
[3] Hainan Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Haikou, Peoples R China
[4] Gastroenterol Clin Med Ctr Hainan Prov, Haikou, Peoples R China
[5] Hainan Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Yehai Ave 368, Haikou, Hainan, Peoples R China
来源
DIABETES METABOLIC SYNDROME AND OBESITY | 2023年 / 16卷
关键词
metabolic-associated fatty liver disease; MAFLD; hospital staffs; risk factors; triglyceride-glucose index; TyG; red blood cell; RBC; H; pylori infection; RED-BLOOD-CELL; URIC-ACID; DISTRIBUTION WIDTH; MORTALITY; CIRRHOSIS; FIBROSIS; GLUCOSE;
D O I
10.2147/DMSO.S407657
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The prevalence of metabolism-related fatty liver disease (MAFLD) has been rarely reported in hospital staffs. The aim of this study was to assess the prevalence and risk factors for MAFLD in hospital staffs aged >= 18 years. Methods: Based on type B ultrasonic, hospital staffs who underwent medical examinations at the second Affiliated Hospital of Hainan Medical University from January 2022 to March 2022 were classified into health control group (661 subjects) and MAFLD group (223 subjects), demographic, biochemical and blood examination information were compared between 2 groups. Independent risk factors for MAFLD were determined by logistic regression. Predictive values of risk factors of MAFLD were evaluated by Results: The prevalence of MAFLD was 33.7%. Older age (OR=1.08, p<0.001), H. pylori infection (OR=0.234, p=0.02), triglycerideglucose (TyG) (OR=7.001, p<0.001), low-density lipoprotein cholesterol (LDL-C) (OR=2.076, p=0.028), red blood cell (RBC) (OR=2.386, p=0.001), eating out (OR=0.048, p=0.001), regular exercise (OR=23.017, p<0.001), and overweight (OR=3.891, p=0.003) were independently associated factors for MAFLD. The AUC of model predicting MAFLD is 0.910 [95% CI (0.886, 0.934)], with 0.794 sensitivity, 0.908 specificity. The diagnostic value of model was higher in the female MAFLD group after stratified analysis according to gender. The model showed that TyG was the factor contributing more to MAFLD. The diagnostic value of TyG was higher in the female MAFLD group than male MAFLD group. Conclusion: The prevalence of MAFLD among hospital staffs was 33.7%. TyG can be used to predict MAFLD especially for female hospital staffs for early intervention.
引用
收藏
页码:1221 / 1234
页数:14
相关论文
共 50 条
  • [1] Prevalence and Risk Factors of Metabolic-Associated Fatty Liver Disease among 73,566 Individuals in Beijing, China
    Yuan, Qianli
    Wang, Huai
    Gao, Pei
    Chen, Weixin
    Lv, Min
    Bai, Shuang
    Wu, Jiang
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [2] Prevalence and risk factors of liver fibrosis in patients with metabolic-associated fatty liver disease undergoing bariatric surgery
    Elsayed, Amr
    Hassnine, Alshymaa
    Gayyed, Mariana F.
    Saied, Fatma
    Abdelzaher, Mohamed A.
    Fouad, Yasser
    Mostafa, Alaa M.
    Khalaf, Mohamed
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2024, 10 (04) : 240 - 248
  • [3] Metabolic-associated fatty liver disease and the risk of cardiovascular disease
    Zhang, Pengwei
    Dong, Xianhui
    Zhang, Wei
    Wang, Shiyin
    Chen, Chen
    Tang, Jiake
    You, Yao
    Hu, Siqi
    Zhang, Shenghui
    Wang, Chunyi
    Wen, Wen
    Zhou, Mengyun
    Tan, Tao
    Qi, Guanming
    Li, Li
    Wang, Mingwei
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (01)
  • [4] Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents
    Riekki, Hanna
    Aitokari, Linnea
    Kivela, Laura
    Lahti, Siiri
    Hiltunen, Pauliina
    Vuorela, Nina
    Huhtala, Heini
    Lakka, Timo A.
    Kurppa, Kalle
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [5] Risk factors and cardio-metabolic outcomes associated with metabolic-associated fatty liver disease in childhood
    de Groot, Jasmin
    Santos, Susana
    Geurtsen, Madelon L.
    Felix, Janine F.
    Jaddoe, Vincent W. V.
    ECLINICALMEDICINE, 2023, 65
  • [6] Metabolic-associated Fatty Liver Disease
    Zheng, Ming-Hua
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (06) : 793 - 794
  • [7] Nonalcoholic Fatty Liver Disease Without Metabolic-associated Fatty Liver Disease and the Risk of Metabolic Syndrome
    Sinn, Dong Hyun
    Kang, Danbee
    Choi, Sung Chul
    Hong, Yun Soo
    Zhao, Di
    Guallar, Eliseo
    Park, Yewan
    Cho, Juhee
    Gwak, Geum-Youn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (07) : 1873 - +
  • [8] Association between maternal factors and risk of metabolic-associated fatty liver disease in offspring
    De Ruyter, Hanna
    Aitokari, Linnea
    Jaaskelainen, Tiina
    Huhtala, Heini
    Laivuori, Hannele
    Kurppa, Kalle
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 : 3 - 3
  • [9] INCREASED RISK OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE AND LIVER FIBROSIS IN INFLAMMATORY BOWEL DISEASE INDEPENDENT OF CLASSIC METABOLIC RISK FACTORS
    Rodriguez Duque, Juan Carlos
    Iruzubieta, Paula
    Rivas, Coral
    Jose Garcia, Maria
    Pascual, Marta
    Castro, Beatriz
    Garcia, Agustin
    Garcia-Nieto, Enrique
    Curiel, Soraya
    Luisa Cagigal, Maria
    Lopez-Montejo, Lorena
    Fernandez, Tatiana
    Rasines, Laura
    Ignacio Fortea, Jose
    Pedro Vague, Jose
    Rivero, Monserrat
    Teresa Arias, Maria
    Crespo Garcia, Javier
    HEPATOLOGY, 2020, 72 : 975 - 976
  • [10] Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China
    Chang, Mingxing
    Shao, Zhihao
    Wei, Wei
    Shen, Peipu
    Shen, Guifang
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14